Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Kestra Medical Technologies Reaches Analyst Target Price

In recent trading, shares of Kestra Medical Technologies Ltd (Symbol: KMTS) have crossed above the average analyst 12-month target price of $28.62, changing hands for $29.37/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: d

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

Read the original at nasdaq.com →

More in Finance & Markets

More from Tuesday 20 October →